Trifocal IOL solutions for all your patients
When expectations and outcomes align
Patient expectations from lens surgery are changing, with an increasing desire to be spectacle free as they continue to lead highly active and social lifestyles until much later in life.
Whether your patients are having cataract surgery or visiting you for refractive enhancement, our complete family of trifocal IOLs are clinically proven to provide them with the best visual outcomes.
- RayOne Trifocal preloaded IOL — for placement in the capsular bag.
- RayOne Trifocal Toric preloaded IOL — for placement in the capsular bag and correction of preoperative corneal astigmatism.
- Sulcoflex Trifocal supplementary IOL — for placement in the ciliary sulcus, with optional correction of refractive change or error.
Optimised diffractive design
Our family of trifocal IOLs use Rayner’s patented diffractive profile that was designed in partnership with a leading European technology institute. This new design of diffractive technology is the most advanced optic in our history and possibly the most advanced in the industry. The diffractive surface is a construct of two profiles to form our patented design:
Graphical representations only of diffractive surface pattern.
Diffractive optic design
Our patented diffractive step trifocal technology uses 16 diffractive rings across a 4.5 mm diffractive zone, with the outer annulus providing pure monofocal distance correction for superior mesopic performance.
Our patented diffractive step trifocal
technology reduces light loss to only 11%
• 89% of light is transmitted to the retina with a pupil of 3.0 mm
• Half the light is allocated for distance
• Remaining light is divided between near and intermediate vision
Light energy split with a 3.0 mm pupil:
Comfortable transition from near to distance activities
Our trifocal optic improves intermediate visual acuity, enabling patients to feel more comfortable transitioning from near to distance activities.
Clinically-proven and industry leading trifocal technology
Comparable outcomes
In a retrospective study of RayOne Trifocal and Sulcoflex Trifocal in 40 eyes, the defocus curve shows comparable visual acuity results and reports similar outcomes.1
Less photic phenomena
In a prospective study of 60 eyes, a statistically significant difference favouring the RayOne Trifocal versus the FineVision POD F was achieved in an objective evaluation of photic phenomenon.2
Less photic phenomena and increased patient satisfaction
In a prospective comparative study of 64 eyes of 32 patients, the RayOne Trifocal group is associated with better scores for glare, symptoms and near and distance VA against the PanOptix Trifocal group.15
100% spectacle independence
In a prospective study of 16 eyes implanted with RayOne Trifocal, 100% of patients achieved spectacle independence and agreed they would have the operation again at 1 month follow up.3
Download Trifocal IOL Brochure
Download PDF
Important Notice
Trifocal IOLs are medical devices. Please read the Instructions for Use carefully before use. For professional use only. Not all products are available in all markets. Contact your local Mert Medical Solutions representative for availability and regulatory status in your region. References: (1) Retrospective study, data on file. (2) Prospective study vs. FineVision POD F, 60 eyes. (3) Prospective study, 16 eyes. (15) RayOne Trifocal vs. PanOptix, 64 eyes, 32 patients.